The Food and Drug Administration (FDA) recently released new draft guidance documents to clarify its approach to regulating software as a medical device.
The first draft guidance, Clinical and Patient Decision Support Software, addresses provision of the 21st Century Cures Act that exempts certain clinical decision support software from the definition of a medical device.
To read more, please visit healthindustrywashingtonwatch.com.